Efforts to continue to promote and expand access to COVID-19 vaccines reached major milestones this week, as the holiday season draws near.
OSHA Vaccination Mandate -
In early September, President Biden released a...more
This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more
A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more
The COVID-19 vaccine approval process reached a major milestone, but the fourth U.S. wave of the COVID-19 virus has prompted some sobering projections about the future of the pandemic.
COVID-19 Vaccine Receives Full FDA...more
Once an innovative outlier in the world of health and life sciences, telemedicine has exponentially gained ground in the current landscape shaped by COVID-19 restrictions. Ann Mond Johnson — CEO of the American Telemedicine...more
Vaccine news dominated the COVID-19 headlines this week, as the ongoing vaccine roll-out hit a snag and leaders contemplated the potential for annual COVID-19 booster shots....more
With his initial goal of 100 million vaccine doses behind us, President Biden announces plans to double that number by his 100th day in office. As a new study brings promising results for vaccinated mothers, U.S. and...more
As a second COVID-19 wave hits Europe, many countries are implementing lockdown restrictions to flatten the curve. The second wave coincides with a pause in two vaccine clinical trials and the emergence of some documented...more